{"id":15410,"date":"2019-01-18T00:00:00","date_gmt":"2019-01-18T00:00:00","guid":{"rendered":"http:\/\/medgoo.com\/index.php\/2019\/01\/18\/fda-panel-has-tie-vote-on-new-type-1-diabetes-drug\/"},"modified":"2019-01-22T16:56:30","modified_gmt":"2019-01-22T16:56:30","slug":"fda-panel-has-tie-vote-on-new-type-1-diabetes-drug","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2019\/01\/18\/fda-panel-has-tie-vote-on-new-type-1-diabetes-drug\/","title":{"rendered":"FDA Panel Has Tie Vote on New Type 1 Diabetes Drug"},"content":{"rendered":"<h3>Zynquista is a once-daily pill meant to help type 1 diabetes patients manage their blood glucose levels<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>FRIDAY, Jan. 18, 2019 (HealthDay News) &#8212; A U.S. Food and Drug Administration advisory panel vote on whether to recommend approval of the first oral medication for type 1 diabetes ended in an 8-8 tie Thursday.<\/p>\n<p>Despite that result, the FDA is expected to decide by the end of March whether the drug &#8212; sotagliflozin, brand name Zynquista &#8212; should be made available in the United States, <i>The New York Times<\/i> reported. The drug, used along with insulin, is a once-daily pill meant to help type 1 diabetes patients manage their blood glucose levels.<\/p>\n<p>Some of the advisory panel members voted against Zynquista because it carries an increased risk for diabetic ketoacidosis, <i>The Times<\/i> reported.<\/p>\n<p>Drug makers Sanofi and Lexicon Pharmaceuticals said they will continue to work with the FDA through the review process for the drug.<\/p>\n<p><a href=\"https:\/\/www.nytimes.com\/2019\/01\/17\/health\/fda-diabetes-drug-sanofi.html\" target=\"_new\"><i>The New York Times<\/i> Article<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2019 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zynquista is a once-daily pill meant to help type 1 diabetes patients manage their blood glucose levels<\/p>\n","protected":false},"author":6,"featured_media":15487,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-15410","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/15410","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=15410"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/15410\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/15487"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=15410"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=15410"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=15410"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}